MBX Biosciences, Inc. (MBX) Stock Statistics & Valuation Metrics

MBX Biosciences, Inc. has a market cap or net worth of $365.66M. The enterprise value is $723.14M.

MBX Biosciences, Inc. has 33,424,370 shares outstanding. The number of shares has decreased by -2.65% in one year.

MBX Biosciences, Inc.’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -26.47%.

The current PE Ratio of MBX Biosciences, Inc. is -9.94. MBX Biosciences, Inc.’s PEG ratio is -0.95.

In the last 12 months, MBX Biosciences, Inc. had revenue of 0.00 and earned -61.92M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -53.38M and capital expenditures -179.00K, giving a free cash flow of -53.56M billion.

MBX Biosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

MBX Biosciences, Inc. upcoming earnings date is May 12, 2025, TBA Not Confirmed.

MBX Biosciences, Inc. as a current ratio of 24.19, with Debt / Equity ratio of -0.45%

In the past 12 months, MBX Biosciences, Inc. has paid 0.00 in taxes.

MBX Biosciences, Inc. EV to EBITDA ratio is -8.33, with an EV/FCF ratio of -10.19.

MBX Biosciences, Inc. has $240.79M in cash and marketable securities with $130.00K in debt, giving a net cash position of -$240.66M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for MBX Biosciences, Inc. is $39.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy